PER977

· Perosphere Pharmaceuticals Inc (subsidiary of AMAG Pharmaceuticals, Inc.)

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PER977, covering 2020-05-21 to 2020-05-21. Get the full timeline:

Most recent: Clinical Trial Update: Study of PER977 Administered to Subjects With Steady State Edoxaban Dosing and Re-anticoagulation With Edoxaban [Phase 2]

See pricing